Global Panitumumab Market Growth (Status and Outlook) 2022-2028
- LP 4798482
- 63 Pages
- January 2022
- Pharmaceuticals
The United States Panitumumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Panitumumab market, reaching US$ million by the year 2028. As for the Europe Panitumumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Panitumumab players cover Amgen, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Panitumumab market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Drug store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Panitumumab Market Size 2017-2028
2.1.2 Panitumumab Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Panitumumab Segment by Type
2.2.1 100 mg/5 mL single-dose vials
2.2.2 400 mg/20 mLsingle-dose vials
2.3 Panitumumab Market Size by Type
2.3.1 Panitumumab Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Panitumumab Market Size Market Share by Type (2017-2022)
2.4 Panitumumab Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Panitumumab Market Size by Application
2.5.1 Panitumumab Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Panitumumab Market Size Market Share by Application (2017-2022)
3 Panitumumab Market Size by Player
3.1 Panitumumab Market Size Market Share by Players
3.1.1 Global Panitumumab Revenue by Players (2020-2022)
3.1.2 Global Panitumumab Revenue Market Share by Players (2020-2022)
3.2 Global Panitumumab Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Panitumumab by Regions
4.1 Panitumumab Market Size by Regions (2017-2022)
4.2 Americas Panitumumab Market Size Growth (2017-2022)
4.3 APAC Panitumumab Market Size Growth (2017-2022)
4.4 Europe Panitumumab Market Size Growth (2017-2022)
4.5 Middle East & Africa Panitumumab Market Size Growth (2017-2022)
5 Americas
5.1 Americas Panitumumab Market Size by Country (2017-2022)
5.2 Americas Panitumumab Market Size by Type (2017-2022)
5.3 Americas Panitumumab Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Panitumumab Market Size by Region (2017-2022)
6.2 APAC Panitumumab Market Size by Type (2017-2022)
6.3 APAC Panitumumab Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Panitumumab by Country (2017-2022)
7.2 Europe Panitumumab Market Size by Type (2017-2022)
7.3 Europe Panitumumab Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Panitumumab by Region (2017-2022)
8.2 Middle East & Africa Panitumumab Market Size by Type (2017-2022)
8.3 Middle East & Africa Panitumumab Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Panitumumab Market Forecast
10.1 Global Panitumumab Forecast by Regions (2023-2028)
10.1.1 Global Panitumumab Forecast by Regions (2023-2028)
10.1.2 Americas Panitumumab Forecast
10.1.3 APAC Panitumumab Forecast
10.1.4 Europe Panitumumab Forecast
10.1.5 Middle East & Africa Panitumumab Forecast
10.2 Americas Panitumumab Forecast by Country (2023-2028)
10.2.1 United States Panitumumab Market Forecast
10.2.2 Canada Panitumumab Market Forecast
10.2.3 Mexico Panitumumab Market Forecast
10.2.4 Brazil Panitumumab Market Forecast
10.3 APAC Panitumumab Forecast by Region (2023-2028)
10.3.1 China Panitumumab Market Forecast
10.3.2 Japan Panitumumab Market Forecast
10.3.3 Korea Panitumumab Market Forecast
10.3.4 Southeast Asia Panitumumab Market Forecast
10.3.5 India Panitumumab Market Forecast
10.3.6 Australia Panitumumab Market Forecast
10.4 Europe Panitumumab Forecast by Country (2023-2028)
10.4.1 Germany Panitumumab Market Forecast
10.4.2 France Panitumumab Market Forecast
10.4.3 UK Panitumumab Market Forecast
10.4.4 Italy Panitumumab Market Forecast
10.4.5 Russia Panitumumab Market Forecast
10.5 Middle East & Africa Panitumumab Forecast by Region (2023-2028)
10.5.1 Egypt Panitumumab Market Forecast
10.5.2 South Africa Panitumumab Market Forecast
10.5.3 Israel Panitumumab Market Forecast
10.5.4 Turkey Panitumumab Market Forecast
10.5.5 GCC Countries Panitumumab Market Forecast
10.6 Global Panitumumab Forecast by Type (2023-2028)
10.7 Global Panitumumab Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Panitumumab Product Offered
11.1.3 Amgen Panitumumab Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
12 Research Findings and Conclusion
Table 1. Panitumumab Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 100 mg/5 mL single-dose vials
Table 3. Major Players of 400 mg/20 mLsingle-dose vials
Table 4. Panitumumab Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Panitumumab Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Panitumumab Market Size Market Share by Type (2017-2022)
Table 7. Panitumumab Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Panitumumab Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Panitumumab Market Size Market Share by Application (2017-2022)
Table 10. Global Panitumumab Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Panitumumab Revenue Market Share by Player (2020-2022)
Table 12. Panitumumab Key Players Head office and Products Offered
Table 13. Panitumumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Panitumumab Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Panitumumab Market Size Market Share by Regions (2017-2022)
Table 18. Americas Panitumumab Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Panitumumab Market Size Market Share by Country (2017-2022)
Table 20. Americas Panitumumab Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Panitumumab Market Size Market Share by Type (2017-2022)
Table 22. Americas Panitumumab Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Panitumumab Market Size Market Share by Application (2017-2022)
Table 24. APAC Panitumumab Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Panitumumab Market Size Market Share by Region (2017-2022)
Table 26. APAC Panitumumab Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Panitumumab Market Size Market Share by Type (2017-2022)
Table 28. APAC Panitumumab Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Panitumumab Market Size Market Share by Application (2017-2022)
Table 30. Europe Panitumumab Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Panitumumab Market Size Market Share by Country (2017-2022)
Table 32. Europe Panitumumab Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Panitumumab Market Size Market Share by Type (2017-2022)
Table 34. Europe Panitumumab Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Panitumumab Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Panitumumab Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Panitumumab Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Panitumumab Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Panitumumab Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Panitumumab Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Panitumumab Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Panitumumab
Table 43. Key Market Challenges & Risks of Panitumumab
Table 44. Key Industry Trends of Panitumumab
Table 45. Global Panitumumab Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Panitumumab Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Panitumumab Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Panitumumab Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Panitumumab Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Panitumumab Market Size Market Share Forecast by Application (2023-2028)
Table 51. Amgen Details, Company Type, Panitumumab Area Served and Its Competitors
Table 52. Amgen Panitumumab Product Offered
Table 53. Amgen Panitumumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Amgen Main Business
Table 55. Amgen Latest Developments
List of Figures
Figure 1. Panitumumab Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Panitumumab Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Panitumumab Market Size Market Share by Type in 2021
Figure 7. Panitumumab in Hospital
Figure 8. Global Panitumumab Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Panitumumab in Drug store
Figure 10. Global Panitumumab Market: Drug store (2017-2022) & ($ Millions)
Figure 11. Global Panitumumab Market Size Market Share by Application in 2021
Figure 12. Global Panitumumab Revenue Market Share by Player in 2021
Figure 13. Global Panitumumab Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Panitumumab Market Size 2017-2022 ($ Millions)
Figure 15. APAC Panitumumab Market Size 2017-2022 ($ Millions)
Figure 16. Europe Panitumumab Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Panitumumab Market Size 2017-2022 ($ Millions)
Figure 18. Americas Panitumumab Value Market Share by Country in 2021
Figure 19. Americas Panitumumab Consumption Market Share by Type in 2021
Figure 20. Americas Panitumumab Market Size Market Share by Application in 2021
Figure 21. United States Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Panitumumab Market Size Market Share by Region in 2021
Figure 26. APAC Panitumumab Market Size Market Share by Application in 2021
Figure 27. China Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Panitumumab Market Size Market Share by Country in 2021
Figure 34. Europe Panitumumab Market Size Market Share by Type in 2021
Figure 35. Europe Panitumumab Market Size Market Share by Application in 2021
Figure 36. Germany Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Panitumumab Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Panitumumab Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Panitumumab Market Size Market Share by Application in 2021
Figure 44. Egypt Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Panitumumab Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Panitumumab Market Size 2023-2028 ($ Millions)
Figure 50. APAC Panitumumab Market Size 2023-2028 ($ Millions)
Figure 51. Europe Panitumumab Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Panitumumab Market Size 2023-2028 ($ Millions)
Figure 53. United States Panitumumab Market Size 2023-2028 ($ Millions)
Figure 54. Canada Panitumumab Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Panitumumab Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Panitumumab Market Size 2023-2028 ($ Millions)
Figure 57. China Panitumumab Market Size 2023-2028 ($ Millions)
Figure 58. Japan Panitumumab Market Size 2023-2028 ($ Millions)
Figure 59. Korea Panitumumab Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Panitumumab Market Size 2023-2028 ($ Millions)
Figure 61. India Panitumumab Market Size 2023-2028 ($ Millions)
Figure 62. Australia Panitumumab Market Size 2023-2028 ($ Millions)
Figure 63. Germany Panitumumab Market Size 2023-2028 ($ Millions)
Figure 64. France Panitumumab Market Size 2023-2028 ($ Millions)
Figure 65. UK Panitumumab Market Size 2023-2028 ($ Millions)
Figure 66. Italy Panitumumab Market Size 2023-2028 ($ Millions)
Figure 67. Russia Panitumumab Market Size 2023-2028 ($ Millions)
Figure 68. Spain Panitumumab Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Panitumumab Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Panitumumab Market Size 2023-2028 ($ Millions)
Figure 71. Israel Panitumumab Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Panitumumab Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Panitumumab Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
